Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies Read more about Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies
TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure Read more about TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure
Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction Read more about Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction
A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease Read more about A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia Read more about A Study of INCB050465 in Participants With Autoimmune Hemolytic Anemia
To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Read more about To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents Read more about Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
The REPLACE Registry for Cholbam® (Cholic Acid) Read more about The REPLACE Registry for Cholbam® (Cholic Acid)
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke Read more about AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke